Perspective Therapeutics Inc (CATX)
3.77
+0.30
(+8.65%)
USD |
NYAM |
Nov 25, 13:02
Perspective Therapeutics Net Income (Annual): -46.51M for Dec. 31, 2023
Net Income (Annual) Chart
Historical Net Income (Annual) Data
Date | Value |
---|---|
December 31, 2023 | -46.51M |
December 31, 2022 | -7.335M |
June 30, 2022 | -7.272M |
June 30, 2021 | -3.387M |
June 30, 2020 | -3.446M |
June 30, 2019 | -5.144M |
June 30, 2018 | -6.70M |
June 30, 2017 | -6.162M |
June 30, 2016 | -4.711M |
June 30, 2015 | -3.681M |
June 30, 2014 | -5.959M |
June 30, 2013 | -3.857M |
June 30, 2012 | -3.489M |
June 30, 2011 | -2.842M |
June 30, 2010 | -4.034M |
June 30, 2009 | -6.161M |
Date | Value |
---|---|
June 30, 2008 | -8.558M |
June 30, 2007 | -9.605M |
June 30, 2006 | -8.218M |
June 30, 2005 | 274.37M |
September 30, 2004 | 0.0758M |
September 30, 2003 | -0.06M |
September 30, 2002 | -0.0591M |
September 30, 2001 | 0.2351M |
September 30, 2000 | -0.0656M |
September 30, 1999 | 1.824M |
September 30, 1998 | -0.1395M |
September 30, 1997 | -0.4261M |
September 30, 1996 | -2.152M |
September 30, 1995 | -0.9392M |
September 30, 1994 | -0.4376M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Annual) Range, Past 5 Years
-46.51M
Minimum
2023
-3.387M
Maximum
2021
-13.59M
Average
-7.272M
Median
2022
Net Income (Annual) Benchmarks
Plus Therapeutics Inc | -13.32M |
Retractable Technologies Inc | -7.011M |
InfuSystems Holdings Inc | 0.872M |
Xtant Medical Holdings Inc | 0.66M |
Catheter Precision Inc | -70.57M |